Revenue
2022
2023
2024
2025
Orchestra BioMed Holdings, Inc. (OBIO)
Price—Loading quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $33.5M | $2.6M | $2.8M | $3.5M | — |
| Research & development | $58.2M | $42.8M | $33.8M | $21.9M | — |
| Operating income | −$51.8M | −$64.3M | −$51.5M | −$32.7M | −$394,756 |
| EBITDAderived | −$51.5M | −$64.0M | −$51.2M | −$32.4M | — |
| Net income | −$52.7M | −$61.0M | −$49.1M | −$33.6M | −$378,753 |
| Basic EPSper diluted share | -$1.11 | -$1.66 | -$1.48 | -$2.24 | -$0.02 |
| Diluted EPSper diluted share | -$1.11 | -$1.66 | -$1.48 | -$2.24 | -$0.02 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026Form 4 | Hochman David PSee Remarks | BuyCommon Stock, par value $0.0001 per share ("Common Stock") | 5.0K | $3.83 | $19.1K | 1.06M |
| Jun 1, 2026Form 4 · 10b5-1 | Sherman DarrenSee Remarks | SellCommon Stock, par value $0.0001 per share | 15.0K | $3.87 | $58.0K | 1.18M |
| May 18, 2026Form 4 | Aryeh JasonDirector | BuyCommon Stock, par value $0.0001 per share | 665 | $3.75 | $2.5K | 118.1K |
| May 15, 2026Form 4 | Aryeh JasonDirector | BuyCommon Stock, par value $0.0001 per share | 9.0K | $3.90 | $35.0K | 117.5K |
| May 15, 2026Form 4 | Hochman David PSee Remarks | BuyCommon Stock, par value $0.0001 per share ("Common Stock") | 5.0K | $3.77 | $18.9K | 1.06M |